An interim analysis of quality of life in patients with relapsing-remitting multiple sclerosis treated with delayed-release dimethyl fumarate

被引：0
|
作者：
Sarda, S. P. [6 ]
Kita, M. [1 ]
Fox, R. J. [2 ]
Gold, R. [3 ]
Giovannoni, G. [4 ]
Phillips, T. [5 ]
Okwuokenye, M. [6 ]
Kong, J. [6 ]
Zhang, R. [6 ]
Kurukulasuriya, N. C. [6 ]
Kappos, L. [7 ]
机构：
[1] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH USA
[3] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[4] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[5] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[6] Biogen Idec Inc, Cambridge, MA USA
[7] Univ Basel Hosp, Basel Neurol, CH-4031 Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P790
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [21] Safety profile of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    JOURNAL OF NEUROLOGY, 2014, 261 : S439 - S439
  • [22] COST-EFFECTIVENESS ANALYSIS OF DELAYED-RELEASE DIMETHYL FUMARATE FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gasche, D.
    Restovic, G.
    Casado, V
    Ramirez-Boix, P.
    Martinez Lopez, J.
    VALUE IN HEALTH, 2015, 18 (07) : A755 - A755
  • [23] Delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis - findings from a real-world setting in Russian Federation
    Davydovskaya, M.
    Pozhidaeva, N.
    Dubchenko, E.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 934 - 935
  • [24] Delayed-release Dimethyl Fumarate Demonstrates Sustained Efficacy over Nine Years in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Bar-Or, Amit
    Fox, Robert J.
    Chen, Chongshu
    Miller, Catherine
    NEUROLOGY, 2019, 92 (15)
  • [25] Safety and Efficacy of Delayed-release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from Asia-Pacific and Other Countries: Interim Analysis of the APEX Extension Study
    Saida, Takahiko
    Yamamura, Takashi
    Kondo, Takayuki
    Yun, Jang
    Li, Jie
    Forsythe, Beverley
    Sheikh, Sarah, I
    Zhu, Bing
    NEUROLOGY, 2017, 88
  • [26] Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM
    Fernandez, Oscar
    Giovannoni, Gavin
    Fox, Robert J.
    Gold, Ralf
    Phillips, J. Theodore
    Potts, James
    Okwuokenye, Macaulay
    Marantz, Jing L.
    CLINICAL THERAPEUTICS, 2017, 39 (08) : 1671 - 1679
  • [27] Delayed-release dimethyl fumarate demonstrates sustained efficacy over nine years in newly diagnosed patients with relapsing-remitting multiple sclerosis
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Bar-Or, A.
    Fox, R. J.
    Chen, C.
    Miller, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 498 - 499
  • [28] Safety profile of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 678 - 678
  • [29] Delayed-release dimethyl fumarate and health-related quality of life (HRQoL) in relapsing-remitting multiple sclerosis (RRMS) patients according to prior therapy: integrated analysis of DEFINE and CONFIRM
    Kappos, L.
    Fox, R. J.
    Gold, R.
    Kita, M.
    Phillips, J. T.
    Sarda, S. P.
    Zhong, L.
    Niecko, T.
    Kurukulasuriya, N. C.
    Giovannoni, G.
    JOURNAL OF NEUROLOGY, 2014, 261 : S306 - S306
  • [30] Delayed-release dimethyl fumarate and health-related quality of life (HRQoL) in relapsing-remitting multiple sclerosis (RRMS) patients according to prior therapy: integrated analysis of DEFINE and CONFIRM
    Kappos, L.
    Fox, R. J.
    Gold, R.
    Kita, M.
    Phillips, J. T.
    Sarda, S. P.
    Zhong, L.
    Niecko, T.
    Kurukulasuriya, N. C.
    Giovannoni, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 462 - 462
12345